疼痛管理デバイス市場- 世界の産業規模、シェア、動向、機会、予測、製品別、購入方法別、用途別、エンドユーザー別、地域別、競合別、2019年～2029年

世界の疼痛管理デバイス市場は、2023年に68億2,000万米ドルと評価され、2029年までのCAGRは9.24%で、予測期間中に力強い成長が予測されています。

疼痛管理デバイスの世界市場は、ヘルスケア産業の中でも、疼痛緩和のための革新的なソリューションの提供に焦点を当てたダイナミックな分野です。世界的に高齢化が進み、慢性疼痛疾患の有病率が高まっていることから、効果的な疼痛管理デバイスに対する需要は拡大し続けています。これらの機器には、神経刺激装置、鎮痛薬注入ポンプ、高周波焼灼装置など、幅広い技術と様式が含まれます。

脊髄刺激装置や末梢神経刺激装置などの神経刺激装置は特に顕著で、標的を絞った電気刺激によって痛みの信号を破壊し、神経因性疼痛や背部手術失敗症候群などの症状を緩和します。さらに、鎮痛薬注入ポンプは、脊髄や特定の神経に直接薬剤を投与し、局所的な緩和を提供すると同時に、全身的な副作用を最小限に抑えます。ラジオ波焼灼装置は、ラジオ波から発生する熱を利用して神経を一時的に無力化し、関節炎やファセット関節痛のような症状に長期的な鎮痛効果をもたらします。

市場はまた、経皮的電気神経刺激（TENS）装置や超音波療法装置など、非侵襲的技術の進歩も目の当たりにしており、侵襲的な処置を必要とせずに疼痛を管理するための代替選択肢を提供しています。さらに、疼痛管理デバイスにスマート技術や接続機能を統合することで、遠隔モニタリングや個別化された治療調整が可能になり、患者の転帰が向上しています。

主な市場促進要因

慢性疼痛の有病率の上昇

疼痛管理デバイスの技術進歩

老年人口の拡大

主な市場課題

規制上のハードルとコンプライアンス

償還制限と経済的制約

主な市場動向

非侵襲的・低侵襲治療への嗜好の高まり

スマート技術と接続機能の統合

セグメント別洞察

製品別洞察

用途別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別（電気刺激装置、ラジオ波焼灼療法（RFA）、鎮痛薬注入ポンプ、神経刺激療法）
  • 購入方法別（店頭販売vs処方箋ベース）
  • 用途別（がん、神経障害性疼痛、顔面偏頭痛、筋骨格系障害、その他）
  • エンドユーザー別（病院クリニック、理学療法センター、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 北米の疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 購入方法別
  • 用途別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 購入方法別
  • 用途別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 購入方法別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 購入方法別
  • 用途別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの疼痛管理デバイス市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 製品別
  • 購入方法別
  • 用途別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併・買収
• 製品上市

第13章 競合情勢

• Medtronic Plc
• Boston Scientific Corporation.
• Stryker Corporation.
• Kennedy Lewis Management LP.
• ICU Medical Inc.
• Enovis
• Baxter International Inc
• LivaNova PLC
• Abbott Laboratories Inc
• DJO Global LLC

第14章 戦略的提言

第15章 免責事項

Global Pain Management Device Market was valued at USD 6.82 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.24% through 2029. The Global Pain Management Device Market is a dynamic sector within the healthcare industry focused on providing innovative solutions for pain relief. With an aging population worldwide and an increasing prevalence of chronic pain conditions, the demand for effective pain management devices continues to grow. These devices encompass a wide range of technologies and modalities, including neurostimulation devices, analgesic infusion pumps, radiofrequency ablation devices, and more.

Neurostimulation devices, such as spinal cord stimulators and peripheral nerve stimulators, are particularly prominent, offering targeted electrical stimulation to disrupt pain signals and provide relief for conditions like neuropathic pain and failed back surgery syndrome. Additionally, analgesic infusion pumps deliver medications directly to the spinal cord or specific nerves, offering localized relief while minimizing systemic side effects. Radiofrequency ablation devices use heat generated from radiofrequency waves to disable nerves temporarily, providing long-lasting pain relief for conditions like arthritis and facet joint pain.

The market is also witnessing advancements in non-invasive technologies, including transcutaneous electrical nerve stimulation (TENS) devices and ultrasound therapy devices, which offer alternative options for managing pain without the need for invasive procedures. Moreover, the integration of smart technologies and connectivity features into pain management devices is enhancing patient outcomes by enabling remote monitoring and personalized treatment adjustments.

Key Market Drivers

Rising Prevalence of Chronic Pain

The rising prevalence of chronic pain is a significant driver propelling the growth of the global pain management device market. Chronic pain, defined as persistent pain lasting for more than three to six months, affects millions of individuals worldwide and presents a considerable healthcare challenge. Conditions such as lower back pain, arthritis, neuropathic pain, fibromyalgia, and migraines contribute to the burden of chronic pain, impacting patients' quality of life and productivity.

Several factors contribute to the increasing prevalence of chronic pain. One primary driver is the aging population, with older adults being more susceptible to chronic pain due to age-related degenerative conditions and comorbidities. As life expectancy rises globally, particularly in developed economies, the proportion of elderly individuals experiencing chronic pain is also increasing, driving the demand for effective pain management solutions.

Additionally, lifestyle factors such as sedentary behavior, poor posture, obesity, and stress contribute to the development and exacerbation of chronic pain conditions. Modern lifestyles characterized by long hours of sitting, inadequate physical activity, and high-stress levels contribute to musculoskeletal issues, nerve compression, and systemic inflammation, leading to chronic pain syndromes.

The prevalence of chronic diseases associated with pain, such as diabetes, cardiovascular disease, cancer, and autoimmune disorders, is on the rise globally. These conditions often cause neuropathic pain, inflammatory pain, or pain associated with tissue damage, necessitating comprehensive pain management strategies to improve patients' quality of life.

The socioeconomic impact of chronic pain is substantial, affecting individuals, families, healthcare systems, and economies. Chronic pain often leads to disability, decreased productivity, impaired mobility, and psychological distress, resulting in significant healthcare expenditures and economic losses. As a result, there is a growing recognition of the need for comprehensive pain management approaches that address the multifaceted nature of chronic pain and improve patient outcomes.

Technological Advancements in Pain Management Devices

Technological advancements in pain management devices have revolutionized the treatment landscape, significantly boosting the global pain management device market. These innovations have led to the development of more effective, precise, and minimally invasive solutions for managing both chronic and acute pain conditions. One of the key advancements driving the market is the evolution of neurostimulation devices. Spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) devices deliver electrical impulses to specific nerves or areas of the spinal cord, disrupting pain signals and providing relief for various chronic pain conditions. Recent innovations in neurostimulation technology include smaller and more durable implants, advanced programming capabilities, and improved patient outcomes. These advancements have expanded the applicability of neurostimulation therapy to a broader range of patients, driving market growth.

Drug delivery systems have undergone significant technological advancements, offering targeted and controlled administration of medications for pain relief. Intrathecal drug delivery systems, such as analgesic infusion pumps, deliver pain medications directly to the spinal cord or specific nerves, bypassing the systemic circulation and minimizing side effects. Recent developments in drug delivery technology include programmable pumps with advanced dose titration algorithms, real-time monitoring capabilities, and improved safety features, enhancing patient outcomes and satisfaction.

Minimally invasive procedures facilitated by technological innovations have transformed pain management practices, offering patients less invasive alternatives to traditional surgical interventions. Radiofrequency ablation (RFA) devices, for example, use heat generated from radiofrequency waves to disable nerves temporarily, providing long-lasting pain relief for conditions like arthritis and facet joint pain. Recent advancements in RFA technology include navigational systems, temperature monitoring probes, and advanced imaging modalities, enabling precise targeting of pain-generating nerves and improved clinical outcomes.

Non-invasive techniques such as transcutaneous electrical nerve stimulation (TENS) and high-frequency ultrasound therapy have emerged as effective adjunctive therapies for managing pain. These devices deliver electrical or mechanical stimuli to nerve fibers, modulating pain perception and promoting tissue healing without the need for invasive procedures or medications. Recent technological advancements in TENS and ultrasound therapy devices include wearable designs, wireless connectivity, and customizable treatment parameters, enhancing convenience and patient compliance..

Expanding Geriatric Population

The expanding geriatric population is a significant factor driving the growth of the global pain management device market. As populations age worldwide, there is a corresponding increase in the prevalence of chronic pain conditions among older adults. Age-related degenerative conditions, such as osteoarthritis, degenerative disc disease, and neuropathy, contribute to the burden of chronic pain in the elderly population. Older adults are more susceptible to chronic pain due to age-related changes in musculoskeletal structures, decreased pain tolerance, and the presence of comorbidities. Conditions such as diabetes, cardiovascular disease, and cancer, which become more prevalent with age, often cause or exacerbate chronic pain, necessitating comprehensive pain management strategies to improve the quality of life for older adults.

Older adults frequently experience multiple chronic conditions concurrently, leading to complex pain management needs. Polypharmacy, or the use of multiple medications, is common among older adults and can contribute to medication-related side effects, drug interactions, and treatment non-adherence. Pain management devices offer a non-pharmacological alternative or adjunct to traditional pharmacotherapy, providing targeted pain relief while minimizing the risk of adverse drug reactions and improving treatment adherence among elderly patients.

The socioeconomic impact of chronic pain in the geriatric population is substantial, affecting healthcare systems, economies, and society as a whole. Chronic pain often leads to disability, decreased mobility, impaired quality of life, and increased healthcare utilization, resulting in significant healthcare expenditures and economic burdens. As the geriatric population continues to grow globally, particularly in developed economies with aging populations, there is a pressing need for effective pain management solutions to address the unique needs of older adults.

Pain management devices cater to the specific requirements of the geriatric population by offering targeted, minimally invasive, and customizable treatment options. Neurostimulation devices, analgesic infusion pumps, radiofrequency ablation devices, and non-invasive modalities such as transcutaneous electrical nerve stimulation (TENS) and ultrasound therapy are among the technologies that provide safe and effective pain relief for older adults.

Key Market Challenges

Regulatory Hurdles and Compliance

Regulatory hurdles and compliance challenges pose significant barriers to the growth of the global pain management device market. The development, manufacturing, and commercialization of pain management devices are subject to stringent regulatory requirements imposed by health authorities worldwide. Navigating the complex regulatory landscape involves extensive documentation, rigorous testing, and adherence to specific quality standards, significantly prolonging the time-to-market for new products.

Obtaining regulatory approvals for pain management devices often requires substantial investments of time, resources, and expertise. The regulatory process involves multiple stages, including preclinical testing, clinical trials, and regulatory submissions, each of which requires meticulous planning and execution. Delays in regulatory approvals can impede product launches and limit market access, hindering innovation and market growth.

Compliance with regulatory standards throughout the product lifecycle also presents ongoing challenges for manufacturers. Post-market surveillance obligations, including adverse event reporting, device tracking, and quality management system audits, require continuous monitoring and documentation to ensure compliance. Non-compliance with regulatory requirements can result in sanctions, fines, or product recalls, damaging reputation and eroding consumer trust.

Regulatory discrepancies across different regions add complexity to market entry strategies and increase compliance costs for manufacturers. Variations in regulatory requirements, approval timelines, and labeling requirements necessitate tailored regulatory strategies for each market, contributing to the overall regulatory burden.

Reimbursement Limitations and Economic Constraints

Reimbursement limitations and economic constraints present substantial obstacles to the growth of the global pain management device market. Despite the clinical effectiveness of pain management devices, access to these technologies is often hindered by inadequate reimbursement coverage and economic constraints within healthcare systems.

Limited reimbursement coverage for pain management devices restricts patient access to these innovative therapies, particularly in regions with stringent healthcare budgets or cost-conscious payers. Reimbursement policies vary widely across different jurisdictions, leading to disparities in access to pain management devices based on geographical location and payer preferences. Moreover, reimbursement rates may not adequately reflect the value proposition of pain management devices, discouraging healthcare providers from adopting these technologies and limiting market penetration.

Economic constraints within healthcare systems further exacerbate the reimbursement challenges facing the pain management device market. Budgetary pressures, resource constraints, and competing healthcare priorities compel healthcare organizations to prioritize cost-effective interventions over innovative but expensive technologies. Limited healthcare spending and reimbursement cuts by payers constrain investments in pain management devices, hindering market growth and innovation.

Key Market Trends

Growing Preference for Non-Invasive and Minimally Invasive Treatments

The growing preference for non-invasive and minimally invasive treatments is significantly boosting the global pain management device market. Patients and healthcare providers are increasingly opting for these approaches due to their effectiveness, safety, and reduced recovery times compared to traditional surgical interventions. This trend towards less invasive treatments is reshaping the pain management landscape, driving demand for innovative devices that offer targeted relief with minimal disruption to patients' lives.

Non-invasive techniques such as transcutaneous electrical nerve stimulation (TENS) and high-frequency ultrasound therapy are gaining popularity as they provide pain relief without the need for invasive procedures or medications. TENS devices deliver electrical impulses through electrodes placed on the skin, stimulating nerves and reducing pain perception. High-frequency ultrasound therapy uses focused ultrasound waves to generate heat deep within tissues, providing targeted relief for conditions like musculoskeletal pain and arthritis. These non-invasive modalities offer patients a non-pharmacological alternative to manage pain effectively, reducing reliance on medications and their associated side effects.

Similarly, minimally invasive procedures like radiofrequency ablation (RFA) and nerve blocks are becoming increasingly favored for their ability to provide targeted relief with fewer risks and shorter recovery times compared to traditional surgery. RFA devices use heat generated from radiofrequency waves to disable nerves temporarily, providing long-lasting pain relief for conditions like arthritis and facet joint pain. Nerve blocks involve the injection of local anesthetics or steroids near nerves to block pain signals, offering immediate relief for acute pain episodes. These minimally invasive procedures can often be performed on an outpatient basis, allowing patients to return to their normal activities shortly after treatment.

The preference for non-invasive and minimally invasive treatments is driving innovation in the pain management device market, with manufacturers developing advanced technologies to meet the growing demand. Smart technologies and connectivity features are being integrated into pain management devices to enhance patient experience and treatment outcomes. Remote monitoring capabilities, smartphone apps, and wearable designs enable healthcare providers to personalize treatment plans and track patient progress, improving overall patient satisfaction and adherence to treatment regimens.

Integration of Smart Technologies and Connectivity Features

The integration of smart technologies and connectivity features is playing a pivotal role in boosting the global pain management device market. With the advent of digital health technologies, there has been a paradigm shift towards personalized and patient-centric care. Pain management devices leveraging smart technologies are empowering patients and healthcare providers with real-time data, remote monitoring capabilities, and enhanced treatment outcomes.

One of the key drivers behind the adoption of smart technologies in pain management devices is the demand for personalized treatment options. Every patient's pain experience is unique, and personalized treatment plans tailored to individual needs can significantly improve outcomes. Smart pain management devices offer customizable treatment parameters that can be adjusted based on real-time feedback and patient preferences. For example, wearable neurostimulation devices equipped with smartphone apps allow patients to adjust stimulation settings, track pain levels, and monitor treatment progress, providing a more personalized and adaptive approach to pain management.

The integration of connectivity features enables remote monitoring and data sharing between patients and healthcare providers. Healthcare providers can remotely monitor patient adherence, treatment efficacy, and outcomes, allowing for timely interventions and adjustments to treatment plans as needed. Patients benefit from continuous support and guidance from healthcare professionals, improving treatment adherence and overall patient satisfaction.

Smart pain management devices also facilitate patient education and self-management strategies, empowering patients to take an active role in their pain management journey. Smartphone apps and digital platforms provide educational resources, pain tracking tools, and self-care tips, helping patients better understand their condition and manage their symptoms effectively between healthcare visits. By empowering patients with knowledge and tools to self-manage their pain, smart pain management devices contribute to improved treatment outcomes and enhanced quality of life.

Segmental Insights

Product Insights

Based on the product, the neurostimulation products segment emerged as the dominant segment in the Global Pain Management Device Market in 2023.One of the primary reasons for the dominance of neurostimulation products is their proven efficacy in managing chronic pain. Clinical studies have demonstrated the effectiveness of neurostimulation in providing long-term relief for various types of chronic pain, including neuropathic pain, back pain, and complex regional pain syndrome. As a result, healthcare providers and patients alike have increasingly turned to neurostimulation as a preferred treatment option, driving demand within the market.

Advancements in technology have led to the development of more advanced and customizable neurostimulation devices. These devices offer greater precision and control over the delivery of electrical impulses, allowing for tailored treatment approaches that meet the unique needs of each patient.

Application Insights

Based on the application, the neuropathic pain segment emerged as the dominant segment in the global pain management Device market in 2023.One of the primary reasons for the dominance of the neuropathic pain segment is the prevalence of neuropathic pain conditions worldwide. Conditions such as diabetic neuropathy, post-herpetic neuralgia, and peripheral neuropathy affect millions of individuals globally, severely impacting their quality of life and daily functioning. The debilitating nature of neuropathic pain has led to a pressing need for advanced treatment options, driving the demand for pain management devices tailored specifically to address neuropathic pain symptoms.

Furthermore, technological advancements in pain management devices have led to the development of innovative solutions specifically designed for neuropathic pain relief. Devices such as neurostimulators and transcutaneous electrical nerve stimulation (TENS) units offer targeted therapy by modulating nerve activity and interrupting pain signals associated with neuropathic pain conditions.

Regional Insights

North America emerged as the dominant region in the Global Pain Management Device Market in 2023, holding the largest market share. North America boasts advanced healthcare infrastructure and a robust regulatory framework conducive to the development, approval, and adoption of pain management devices. The region's well-established healthcare system fosters innovation and facilitates the introduction of cutting-edge medical technologies, positioning it at the forefront of the global market.Additionally, the region benefits from a strong healthcare reimbursement system, which encourages patients access to pain management devices. Health insurance coverage and reimbursement policies in North America often include provisions for medical devices, making them more accessible and affordable for patients in need.

Key Market Players

Medtronic Plc

Boston Scientific Corporation

Stryker Corporation

Kennedy Lewis Management LP

ICU Medical Inc

Enovis

Baxter International Inc

LivaNova PLC

Abbott Laboratories Inc

DJO Global LLC

Report Scope:

In this report, the Global Pain Management Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pain Management Device Market,By Product:

• Electrical Stimulators
• Radiofrequency Ablation (RFA)
• Analgesic Infusion Pumps
• Neurostimulation

Pain Management Device Market,By Mode of Purchase:

• Over The Counter
• Prescription-Based

Pain Management Device Market,By Application:

• Cancer
• Neuropathic Pain
• Facial Migraine
• Musculoskeletal Disorder
• Others

Pain Management Device Market,By End User:

• Hospitals Clinics
• Physiotherapy Centers
• Others

Pain Management Device Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pain Management Device Market.

Available Customizations:

Global Pain Management Device Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Pain Management Devices Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Product (Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, Neurostimulation)
  • 5.2.2.By Mode of Purchase (Over-The-Counter v/s Prescription-Based)
  • 5.2.3.By Application (Cancer, Neuropathic Pain, Facial Migraine, Musculoskeletal Disorder, Others)
  • 5.2.4.By End User (Hospitals Clinics, Physiotherapy Centers, Others)
  • 5.2.5.By Region
  • 5.2.6.By Company (2023)
• 5.3.Market Map

6.North America Pain Management Devices Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Product
  • 6.2.2.By Mode of Purchase
  • 6.2.3.By Application
  • 6.2.4.By End User
  • 6.2.5.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Pain Management Devices Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Product
      • 6.3.1.2.2.By Mode of Purchase
      • 6.3.1.2.3.By Application
      • 6.3.1.2.4.By End User
  • 6.3.2.Canada Pain Management Devices Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Product
      • 6.3.2.2.2.By Mode of Purchase
      • 6.3.2.2.3.By Application
      • 6.3.2.2.4.By End User
  • 6.3.3.Mexico Pain Management Devices Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Product
      • 6.3.3.2.2.By Mode of Purchase
      • 6.3.3.2.3.By Application
      • 6.3.3.2.4.By End User

7.Europe Pain Management Devices Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Product
  • 7.2.2.By Mode of Purchase
  • 7.2.3.By Application
  • 7.2.4.By End User
  • 7.2.5.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.France Pain Management Devices Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Product
      • 7.3.1.2.2.By Mode of Purchase
      • 7.3.1.2.3.By Application
      • 7.3.1.2.4.By End User
  • 7.3.2.Germany Pain Management Devices Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Product
      • 7.3.2.2.2.By Mode of Purchase
      • 7.3.2.2.3.By Application
      • 7.3.2.2.4.By End User
  • 7.3.3.United Kingdom Pain Management Devices Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Product
      • 7.3.3.2.2.By Mode of Purchase
      • 7.3.3.2.3.By Application
      • 7.3.3.2.4.By End User
  • 7.3.4.Italy Pain Management Devices Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Product
      • 7.3.4.2.2.By Mode of Purchase
      • 7.3.4.2.3.By Application
      • 7.3.4.2.4.By End User
  • 7.3.5.Spain Pain Management Devices Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Product
      • 7.3.5.2.2.By Mode of Purchase
      • 7.3.5.2.3.By Application
      • 7.3.5.2.4.By End User

8.Asia-Pacific Pain Management Devices Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Product
  • 8.2.2.By Mode of Purchase
  • 8.2.3.By Application
  • 8.2.4.By End User
  • 8.2.5.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Pain Management Devices Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Product
      • 8.3.1.2.2.By Mode of Purchase
      • 8.3.1.2.3.By Application
      • 8.3.1.2.4.By End User
  • 8.3.2.India Pain Management Devices Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Product
      • 8.3.2.2.2.By Mode of Purchase
      • 8.3.2.2.3.By Application
      • 8.3.2.2.4.By End User
  • 8.3.3.Japan Pain Management Devices Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Product
      • 8.3.3.2.2.By Mode of Purchase
      • 8.3.3.2.3.By Application
      • 8.3.3.2.4.By End User
  • 8.3.4.South Korea Pain Management Devices Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Product
      • 8.3.4.2.2.By Mode of Purchase
      • 8.3.4.2.3.By Application
      • 8.3.4.2.4.By End User
  • 8.3.5.Australia Pain Management Devices Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Product
      • 8.3.5.2.2.By Mode of Purchase
      • 8.3.5.2.3.By Application
      • 8.3.5.2.4.By End User

9.South America Pain Management Devices Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Product
  • 9.2.2.By Mode of Purchase
  • 9.2.3.By Application
  • 9.2.4.By End User
  • 9.2.5.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Pain Management Devices Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Product
      • 9.3.1.2.2.By Mode of Purchase
      • 9.3.1.2.3.By Application
      • 9.3.1.2.4.By End User
  • 9.3.2.Argentina Pain Management Devices Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Product
      • 9.3.2.2.2.By Mode of Purchase
      • 9.3.2.2.3.By Application
      • 9.3.2.2.4.By End User
  • 9.3.3.Colombia Pain Management Devices Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Product
      • 9.3.3.2.2.By Mode of Purchase
      • 9.3.3.2.3.By Application
      • 9.3.3.2.4.By End User

10.Middle East and Africa Pain Management Devices Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Product
  • 10.2.2.By Mode of Purchase
  • 10.2.3.By Application
  • 10.2.4.By End User
  • 10.2.5.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Pain Management Devices Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Product
      • 10.3.1.2.2.By Mode of Purchase
      • 10.3.1.2.3.By Application
      • 10.3.1.2.4.By End User
  • 10.3.2.Saudi Arabia Pain Management Devices Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Product
      • 10.3.2.2.2.By Mode of Purchase
      • 10.3.2.2.3.By Application
      • 10.3.2.2.4.By End User
  • 10.3.3.UAE Pain Management Devices Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Product
      • 10.3.3.2.2.By Mode of Purchase
      • 10.3.3.2.3.By Application
      • 10.3.3.2.4.By End User

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Developments
• 12.2.Mergers Acquisitions
• 12.3.Product Launches

13.Competitive Landscape

• 13.1.Medtronic Plc
  • 13.1.1.Business Overview
  • 13.1.2.Company Snapshot
  • 13.1.3.Products Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Recent Developments
  • 13.1.6.SWOT Analysis
• 13.2.Boston Scientific Corporation.
• 13.3.Stryker Corporation.
• 13.4.Kennedy Lewis Management LP.
• 13.5.ICU Medical Inc.
• 13.6.Enovis
• 13.7.Baxter International Inc
• 13.8.LivaNova PLC
• 13.9.Abbott Laboratories Inc
• 13.10.DJO Global LLC

14.Strategic Recommendations

15. About Us Disclaimer